ciglitazone has been researched along with Dermatitis, Atopic in 2 studies
ciglitazone: structure given in second source; PPAR agonist used for type II diabetes
ciglitazone : An aromatic ether that consists of 1,3-thiazolidine-2,4-dione with position 5 substituted by a 4-[(1-methylcyclohexyl)methoxy]benzyl group. A selective PPARgamma agonist.
Dermatitis, Atopic: A chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. It is manifested by lichenification, excoriation, and crusting, mainly on the flexural surfaces of the elbow and knee. In infants it is known as infantile eczema.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Rühl, R | 1 |
Dahten, A | 2 |
Schweigert, FJ | 1 |
Herz, U | 1 |
Worm, M | 2 |
Koch, C | 1 |
Ernst, D | 1 |
Schnöller, C | 1 |
Hartmann, S | 1 |
2 other studies available for ciglitazone and Dermatitis, Atopic
Article | Year |
---|---|
Inhibition of IgE-production by peroxisome proliferator-activated receptor ligands.
Topics: Animals; CD40 Antigens; Cells, Cultured; Dermatitis, Atopic; Female; Humans; Hypoglycemic Agents; Im | 2003 |
Systemic PPARgamma ligation inhibits allergic immune response in the skin.
Topics: Animals; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Dermatitis, Atopic; Disease Models, | 2008 |